Mebiopharm Co., Ltd   Report issue

For profit Phase 2
Founded: Tokyo Japan (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2006
NCT00355888
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now